David Melnick

2.5k total citations
55 papers, 2.0k citations indexed

About

David Melnick is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, David Melnick has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 21 papers in Pharmacology and 15 papers in Infectious Diseases. Recurrent topics in David Melnick's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pneumonia and Respiratory Infections (12 papers) and Antibiotic Resistance in Bacteria (12 papers). David Melnick is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Pneumonia and Respiratory Infections (12 papers) and Antibiotic Resistance in Bacteria (12 papers). David Melnick collaborates with scholars based in United States, United Kingdom and China. David Melnick's co-authors include Tova Meshulam, Amy N. Schilling, Vincent H. Tam, R Sullivan, Harry L. Malech, Elizabeth A. Coyle, Shádi Neshat, Keith Poole, Richard D. Diamond and Thomas P. Lodise and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David Melnick

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Melnick United States	26	707	695	581	569	424	55	2.0k
Weiguo Liu United States	30	960 1.4×	1.3k 1.9×	872 1.5×	1.2k 2.2×	509 1.2×	65	3.4k
Evangelos D. Anastassiou Greece	25	394 0.6×	227 0.3×	457 0.8×	440 0.8×	446 1.1×	81	1.7k
Efthymia Protonotariou Greece	19	348 0.5×	265 0.4×	705 1.2×	247 0.4×	310 0.7×	82	1.5k
Jerina Boelens Belgium	20	734 1.0×	262 0.4×	181 0.3×	487 0.9×	279 0.7×	83	1.8k
Hua Zhou China	24	475 0.7×	260 0.4×	880 1.5×	312 0.5×	586 1.4×	138	2.0k
Ursula Hollenstein Austria	26	399 0.6×	430 0.6×	154 0.3×	287 0.5×	442 1.0×	38	2.0k
Todd Riccobene United States	22	337 0.5×	643 0.9×	473 0.8×	285 0.5×	243 0.6×	50	1.2k
P Van der Auwera Belgium	21	498 0.7×	375 0.5×	266 0.5×	705 1.2×	248 0.6×	70	1.6k
Richard E. Bryant United States	24	936 1.3×	310 0.4×	225 0.4×	713 1.3×	245 0.6×	53	2.1k
Carl L. Pierson United States	22	559 0.8×	154 0.2×	217 0.4×	346 0.6×	245 0.6×	45	1.9k

Countries citing papers authored by David Melnick

Since Specialization

Citations

This map shows the geographic impact of David Melnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Melnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Melnick more than expected).

Fields of papers citing papers by David Melnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Melnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Melnick. The network helps show where David Melnick may publish in the future.

Co-authorship network of co-authors of David Melnick

This figure shows the co-authorship network connecting the top 25 collaborators of David Melnick. A scholar is included among the top collaborators of David Melnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Melnick. David Melnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Lin, Emily Henkle, Brady M. Youngquist, et al.. (2024). Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection. American Journal of Respiratory and Critical Care Medicine. 209(10). 1246–1254. 6 indexed citations

Sewunet, Tsegaye, Mohammad Reza Razavi, Staffan Rosenborg, et al.. (2024). Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial. The Lancet Microbe. 5(4). e355–e365. 3 indexed citations

Bhavnani, Sujata M., et al.. (2023). Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide. Antimicrobial Agents and Chemotherapy. 67(6). e0145122–e0145122. 5 indexed citations

Bleicher, Josh, Robert D. Shaw, Richard J. Barth, et al.. (2023). Surgical Trainee Perspectives on the Opioid Crisis: The Influence of Explicit and Hidden Curricula. Journal of surgical education. 80(6). 786–796. 1 indexed citations

McEntee, Laura, Adam Johnson, Nicola Farrington, et al.. (2019). Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections. Antimicrobial Agents and Chemotherapy. 63(8). 39 indexed citations

Wen, Zehuai, Wei Jia, Huiling Xue, et al.. (2017). Epidemiology, microbiology and treatment implications in adult patients hospitalized with pneumonia in different regions of China: a retrospective study. Journal of Thoracic Disease. 9(10). 3875–3887. 3 indexed citations

Taboada, Maria, David Melnick, Joseph P. Iaconis, et al.. (2015). Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy. 71(4). 862–870. 21 indexed citations

Zhong, Nan, Tieying Sun, Chao Zhuo, et al.. (2014). Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial. The Lancet Infectious Diseases. 15(2). 161–171. 62 indexed citations

Balasubramanian, V., Suresh Solapure, A. K. Ghosh, et al.. (2013). Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis. Antimicrobial Agents and Chemotherapy. 58(1). 495–502. 74 indexed citations

10.

Toltzis, Philip, Michael Dul, Mary Ann O’Riordan, et al.. (2009). Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit*. Pediatric Critical Care Medicine. 10(1). 49–54. 6 indexed citations

11.

Embil, John M., Norberto E. Soto, & David Melnick. (2006). A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus. Clinical Therapeutics. 28(8). 1164–1174. 16 indexed citations

12.

Fabian, Timothy C., Thomas M. File, John M. Embil, et al.. (2005). Meropenem Versus Imipenem-Cilastatin for the Treatment of Hospitalized Patients with Complicated Skin and Skin Structure Infections: Results of a Multicenter, Randomized, Double-Blind Comparative Study. Surgical Infections. 6(3). 269–282. 32 indexed citations

13.

Blumer, Jeffrey L., Lisa Saiman, Michael W. Konstan, & David Melnick. (2005). The Efficacy and Safety of Meropenem and Tobramycin vs Ceftazidime and Tobramycin in the Treatment of Acute Pulmonary Exacerbations in Patients With Cystic Fibrosis. CHEST Journal. 128(4). 2336–2346. 71 indexed citations

14.

Berman, Steven, et al.. (2004). Meropenem Monotherapy for the Treatment of Hospital- Acquired Pneumonia: Results of a Multicenter Trial. Journal of Chemotherapy. 16(4). 362–371. 10 indexed citations

15.

Groß, Peter, Steven M. Asch, Mari M. Kitahata, et al.. (2000). Performance Measures for Guidelines on Preventing Opportunistic Infections in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 30(s1). S85–S93. 5 indexed citations

16.

Kenney, Richard T., Kyung J. Kwon‐Chung, David Melnick, et al.. (1992). Successful Treatment of Systemic Exophiala dermatitidis Infection in a Patient with Chronic Granulomatous Disease. Clinical Infectious Diseases. 14(1). 235–242. 67 indexed citations

17.

Brunkhorst, Beatrice, et al.. (1992). Differential roles of Fc gamma RII and Fc gamma RIII in immune complex stimulation of human neutrophils.. Journal of Biological Chemistry. 267(29). 20659–20666. 40 indexed citations

18.

Melnick, David, et al.. (1988). A novel natural inhibitor from Candida albicans hyphae causing dissociation of the neutrophil respiratory burst response to chemotactic peptides from other post-activation events.. The Journal of Immunology. 140(11). 3893–3899. 25 indexed citations

19.

Pothoulakis, C, R Sullivan, David Melnick, et al.. (1988). Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.. Journal of Clinical Investigation. 81(6). 1741–1745. 98 indexed citations

20.

Meshulam, Tova, Richard D. Diamond, C A Lyman, Deborah R. Wysong, & David Melnick. (1988). Temporal association of calcium mobilization, inositol trisphosphate generation, and superoxide anion release by human neutrophils activated by serum opsonized and nonopsonized particulate stimuli. Biochemical and Biophysical Research Communications. 150(2). 532–539. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact